Implications of ACC/AHA Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus among Several US Networks of Community Health Centers

被引：0
|
作者：
Akhabue, Ehimare
Rittner, Sarah S.
Carroll, Joseph E.
Crawford, Philip M.
Dant, Lydia
Laws, Reesa
Leo, Michael C.
Puro, Jon
Persell, Stephen D.
机构：
来源：
CIRCULATION | 2017年 / 135卷
关键词：
Statins; Guidelines; Diabetes Mellitus;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P324
引用
收藏
页数：3
相关论文
共 26 条
  • [21] ABSENCE OF CORONARY ARTERY CALCIUM IS ASSOCIATED WITH A FAVORABLE ALL CAUSE AND CARDIOVASCULAR DISEASE SPECIFIC MORTALITY RISK AMONG STATIN CANDIDATES ACCORDING TO AMERICAN COLLEGE OF CARDIOLOGY/AMERICAN HEART ASSOCIATION (ACC/AHA) CHOLESTEROL MANAGEMENT GUIDELINES: CAC CONSORTIUM
    Rajan, Tanuja
    Grandhi, Gowtham
    Dardari, Zeina
    Miedema, Michael
    Shaw, Leslee
    Rumberger, John
    Rozanski, Alan
    Al-Mallah, Mouaz H.
    Berman, Daniel
    Budoff, Matthew
    Blaha, Michael
    Nasir, Khurram
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1681 - 1681
  • [22] AHA/ACC/HHS Strategies to Enhance Application of Clinical Practice Guidelines in Patients With Cardiovascular Disease and Comorbid Conditions From the American Heart Association, American College of Cardiology, and US Department of Health and Human Services
    Arnett, Donna K.
    Goodman, Richard A.
    Halperin, Jonathan L.
    Anderson, Jeffrey L.
    Parekh, Anand K.
    Zoghbi, William A.
    CIRCULATION, 2014, 130 (18) : 1662 - +
  • [23] Outcomes Of Pneumonia Hospitalizations Among Adults With And Without Hyperglycemia And Diabetes Mellitus: Preliminary Results From The Centers For Disease Control And Prevention Etiology Of Pneumonia In The Community (epic) Study
    Anjum, H.
    Wunderink, R. G.
    Balk, R.
    Waterer, G. W.
    Grace, B.
    Tulaimat, A.
    Self, W. H.
    Grijalva, C.
    Courtney, M.
    Anderson, E.
    Jain, S.
    Bramley, A.
    Fakhran, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [24] COST-EFFECTIVENESS OF NON-STATIN LIPID-MODIFYING AGENTS FOR PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW
    Abushanab, D.
    Al-Badriyeh, D.
    Marquina, C.
    Bailey, C.
    Jaam, M.
    Liew, D.
    Ademi, Z.
    VALUE IN HEALTH, 2022, 25 (01) : S98 - S98
  • [25] Sulfonylureas use among US veterans with type 2 diabetes mellitus at high risk for cardiovascular disease (CVD) or existing CVD-CREST study: comparison to current treatment guidelines
    Shi, L.
    Kachroo, S.
    Kawabata, H.
    Colilla, S. A.
    Mukherjee, J.
    Iloeje, U.
    Fonseca, V.
    DIABETOLOGIA, 2013, 56 : S389 - S389
  • [26] Position of the Committee, of Epidemiology and Cardiovascular Prevention of the Argentine Federation of Cardiology in joint meeting with Experts in Lipids, about the new guidelines ACC/AHA 2013, (American College of Cardiology / American Heart Association) and the NICE Guides 2014 (National Institute for Health and Care Excellence) to reduce the risk of atherosclerotic cardiovascular disease
    del Sueldo, Mildren
    Lorenzatti, Alberto
    Alcala, Gustavo
    Corral, Pablo
    Cuneo, Carlos
    Francisco de Rosa, Jose
    Lozada, Alfredo
    Carlos Rivas, Juan
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2015, 44 : 6 - 18
123